Mr. Griem’s practice concentrates on intellectual property litigation, particularly patent litigation, as well as trade secret protection, license and technology agreements, strategic portfolio development, and intellectual property issues arising in corporate and finance transactions. He also advises clients on trademark matters, including litigation seeking preliminary injunctions, U.S. Patent and Trademark Office proceedings, and prosecution to obtain federal registration.
Mr. Griem has led major litigation in the fields of pharmaceuticals, diagnostic testing, medical products, consumer electronic products, and semiconductors, among others. His expertise extends to every phase of an infringement case, from pre-suit investigation to fact and expert discovery, summary judgment motions, trial, appeal and settlement. One particular area of expertise is advising clients in complex patent litigations under the Hatch-Waxman Act. He has also handled cases seeking to recover damages for the at-risk launch of a generic pharmaceutical product.
In the spring 2014 semester, Mr. Griem is teaching Biotechnology and the Law.